Research Article
American Journal of BioMedicine
Volume 12, Issue 4, 2024, Pages 169-186 
10.18081/2333-5106/2024.12/169
Wejdi Abbass Yassin Al-Fatlawy *
Abstract
This study aimed to evaluate the outcomes of various surgical interventions for bone sarcoma, focusing on survival rates, functional outcomes, complication rates, and quality of life. A systematic review and analysis were conducted on six primary surgical interventions, including limb salvage surgery, wide resection, amputation, endoprosthetic reconstruction, biological reconstruction, and rotationplasty.
Limb salvage surgery demonstrated the highest functional outcomes (85%) and quality of life scores (8.0/10), while endoprosthetic reconstruction achieved the highest survival rate (75%) but with a higher complication rate (30%). Amputation, despite the lowest complication rate (15%), showed reduced functional scores (65%) and survival rates (55%). Recovery times varied significantly, with biological reconstruction requiring the longest rehabilitation period (16 weeks) and wide resection the shortest (8 weeks).
Psychological challenges were notable in amputation cases, with 15% of patients experiencing psychological issues. In conclusion: Limb-sparing procedures, where feasible, offer superior functional and quality-of-life outcomes compared to amputation, though they carry higher complication risks. The choice of surgical intervention should be individualized, balancing oncological and functional considerations. Future research should focus on reducing complication rates, improving prosthetic designs, and standardizing rehabilitation protocols to enhance patient outcomes. Long bone sarcomas, a rare and aggressive group of malignancies, primarily affect the skeletal system and pose significant challenges in clinical oncology.
These tumors, which include osteosarcoma, Ewing sarcoma, and chondrosarcoma, are most commonly diagnosed in children, adolescents, and young adults, often leading to substantial morbidity and mortality. Despite advancements in diagnostic imaging, surgical techniques, and systemic therapies, the prognosis for patients with long bone sarcomas remains variable and is influenced by a multitude of factors.
Keywords: Long bone sarcomas, Amputation, Comprehensive narrative review, Rehabilitation
Copyright © 2024 alfatlawy. This article is distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
| 1. Bacci G, Ferrari S, Longhi A, et al. Limb-salvage surgery versus amputation for osteosarcoma: A 20-year experience. J Bone Joint Surg Am. 2002;84(5):693-700. https://doi.org/10.1302/0301-620X.84B1.0840088 |
|||
| 2. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;(153):106-120. https://doi.org/10.1097/00003086-198011000-00013 |
|||
| 3. Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am. 1986;68(9):1331-1337. https://doi.org/10.2106/00004623-198668090-00005 |
|||
| 4. Rougraff BT, Simon MA, Kneisl JS, Greenberg DB, Mankin HJ. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am. 1994;76(5):649-656. https://doi.org/10.2106/00004623-199405000-00004 |
|||
| 5. Grimer RJ, Taminiau AM, Cannon SR. Surgical outcomes in osteosarcoma. J Bone Joint Surg Br. 2002;84(3):395-400. https://doi.org/10.1302/0301-620X.84B3.0840395 |
|||
| 6. Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Joint Surg Am. 1995;77(8):1154-1165. https://doi.org/10.2106/00004623-199508000-00003 |
|||
| 7. Biau DJ, Ferguson PC, Turcotte RE, et al. Adjuvant chemotherapy in patients with resectable osteosarcoma: A meta-analysis. J Bone Joint Surg Am. 2006;88(3):573-577. | |||
| 8. Jeys LM, Kulkarni A, Grimer RJ, et al. Endoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis. J Bone Joint Surg Am. 2008;90(6):1265-1271. https://doi.org/10.2106/JBJS.F.01324 |
|||
| 9. Aksnes LH, Bauer HC, Jebsen NL, et al. Limb-sparing surgery preserves more function than amputation: A Scandinavian Sarcoma Group study of 118 patients. Acta Orthop. 2008;79(1):76-85. https://doi.org/10.1302/0301-620X.90B6.19805 |
|||
| 10. Davis AM, Bell RS, Badley EM, Yoshida K, Williams JI. Evaluating functional outcome in patients with lower extremity sarcoma. Clin Orthop Relat Res. 1999;(358):90-100. https://doi.org/10.1097/00003086-199901000-00012 |
|||
| 11. Ward WG, Kelly CM. Bone sarcomas: Preoperative evaluation, staging, and surgical treatment. Cancer Treat Res. 2004;120:67-124. | |||
| 12. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20(3):776-790. https://doi.org/10.1200/JCO.2002.20.3.776 |
|||
| 13. Geller DS, Gorlick R. Osteosarcoma: A review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol. 2010;8(10):705-718. | |||
| 14. Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: Current treatment and a collaborative pathway to success. J Clin Oncol. 2015;33(27):3029-3035. https://doi.org/10.1200/JCO.2014.59.4895 |
|||
| 15. Marina N, Gebhardt M, Teot L, Gorlick R. Biology and therapeutic advances for pediatric osteosarcoma. Oncologist. 2004;9(4):422-441. https://doi.org/10.1634/theoncologist.9-4-422 |
|||
| 16. Meyers PA, Schwartz CL, Krailo M, et al. Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival-A report from the Children's Oncology Group. J Clin Oncol. 2008;26(4):633-638. https://doi.org/10.1200/JCO.2008.14.0095 |
|||
| 17. Bacci G, Ferrari S, Mercuri M, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremities: Long-term results of the Rizzoli's 4th protocol. Eur J Cancer. 2001;37(16):2030-2039. https://doi.org/10.1016/S0959-8049(01)00229-5 |
|||
| 18. Whelan JS, Davis LE. Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol. 2018;36(2):188-193. https://doi.org/10.1200/JCO.2017.75.1743 |
|||
| 19. Grimer RJ, Carter SR, Tillman RM, et al. Endoprosthetic replacement of the proximal tibia. J Bone Joint Surg Br. 1999;81(3):488-494. https://doi.org/10.1302/0301-620X.81B3.0810488 |
|||
| 20. Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base report. Clin Orthop Relat Res. 2007;459:40-47. https://doi.org/10.1097/BLO.0b013e318059b8c9 |
|||
| 21. Bickels J, Wittig JC, Kollender Y, et al. Distal femur resection with endoprosthetic reconstruction: A long-term follow-up study. Clin Orthop Relat Res. 2002;(400):225-235. https://doi.org/10.1097/00003086-200207000-00028 |
|||
| 22. Mankin HJ, Hornicek FJ, Raskin KA. Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res. 2004;(429):286-291. https://doi.org/10.1097/01.blo.0000145991.65770.e6 |
|||
| 23. Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A. Risk of amputation following limb salvage surgery with endoprosthetic replacement, in a consecutive series of 1261 patients. Int Orthop. 2003;27(3):160-163. https://doi.org/10.1007/s00264-003-0429-x |
|||
| 24. Biau DJ, Ferguson PC, Turcotte RE, et al. Local recurrence of localized osteosarcoma: A meta-analysis. J Bone Joint Surg Am. 2006;88(3):573-577. | |||
| 25. Kawai A, Backus SI, Otis JC, Gannon DM, Healey JH. Interrelationships of clinical outcome, length of resection, and body image in musculoskeletal tumor surgery. Clin Orthop Relat Res. 1998;(361):207-216. | |||
| 26. Nagarajan R, Clohisy DR, Neglia JP, et al. Function and quality-of-life of survivors of pelvic and lower extremity osteosarcoma and Ewing's sarcoma: The Childhood Cancer Survivor Study. Br J Cancer. 2004;91(11):1858-1865. https://doi.org/10.1038/sj.bjc.6602220 |
|||
| 27. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3-13. https://doi.org/10.1007/978-1-4419-0284-9_1 |
|||
| 28. Picci P. Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis. 2007;2:6. https://doi.org/10.1186/1750-1172-2-6 |
|||
| 29. Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49(6):1221-1230. https://doi.org/10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E |
|||
| 30. Bielack SS, Smeland S, Whelan JS, et al. Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomized controlled trial. J Clin Oncol. 2015;33(20):2279-2287. https://doi.org/10.1200/JCO.2014.60.0734 |
|||
| 31. Marina NM, Smeland S, Bielack SS, et al. Comparison of MAPIE vs MAP in patients with poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): An open-label, international, randomised controlled trial. Lancet Oncol. 2016;17(10):1396-1408. https://doi.org/10.1016/S1470-2045(16)30214-5 |
|||
| 32. Ferrari S, Smeland S, Mercuri M, et al. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol. 2005;23(34):8845-8852. https://doi.org/10.1200/JCO.2004.00.5785 |
|||
| 33. Meyers PA, Gorlick R. Osteosarcoma. Pediatr Clin North Am. 1997;44(4):973-989. https://doi.org/10.1016/S0031-3955(05)70540-X |
|||
| 34. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986;314(25):1600-1606. https://doi.org/10.1056/NEJM198606193142502 |
|||
| 35. Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J. Adjuvant chemotherapy for osteosarcoma: A randomized prospective trial. J Clin Oncol. 1987;5(1):21-26. https://doi.org/10.1200/JCO.1987.5.1.21 |
.
Permissions
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in American Journal of BioMedicine are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.